FDA Approves New Pancreatic Cancer Drug After Stunning Trial Resultstranslating…

USAIntegrated Whale Media (Steve Forbes)

The therapy is a brand new targeted drug for the disease which experts have labelled as a substantial breakthrough following doubling of survival time in a trial.

Factuality

76/100

Political Bias

Center

Ownership

Integrated Whale Media (Steve Forbes)

Region

USA

Read Original ↗

Share